-
1
-
-
5344266145
-
Cardiopulmonary bypass after 50 years
-
L.H. Edmunds Cardiopulmonary bypass after 50 years N Engl J Med 351 2004 1603 1606
-
(2004)
N Engl J Med
, vol.351
, pp. 1603-1606
-
-
Edmunds, L.H.1
-
2
-
-
78650356248
-
Coagulation considerations for infants and children undergoing cardiopulmonary bypass
-
M.P. Eaton, E.M. Iannoli Coagulation considerations for infants and children undergoing cardiopulmonary bypass Paediatr Anaesth 21 2011 31 42
-
(2011)
Paediatr Anaesth
, vol.21
, pp. 31-42
-
-
Eaton, M.P.1
Iannoli, E.M.2
-
3
-
-
0036945831
-
Coagulation abnormalities in patients with cyanotic congenital heart disease
-
D.K. Tempe, S. Virmani Coagulation abnormalities in patients with cyanotic congenital heart disease J Cardiothorac Vasc Anesth 16 2002 752 765
-
(2002)
J Cardiothorac Vasc Anesth
, vol.16
, pp. 752-765
-
-
Tempe, D.K.1
Virmani, S.2
-
4
-
-
77950802426
-
Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery
-
C.E. Gruenwald, C. Manlhiot, L. Crawford-Lean Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery J Extra Corpor Technol 42 2010 9 19
-
(2010)
J Extra Corpor Technol
, vol.42
, pp. 9-19
-
-
Gruenwald, C.E.1
Manlhiot, C.2
Crawford-Lean, L.3
-
5
-
-
80053568379
-
Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery
-
C. Manlhiot, I.B. Menjak, L.R. Brandao Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery Circulation 124 2011 1511 1519
-
(2011)
Circulation
, vol.124
, pp. 1511-1519
-
-
Manlhiot, C.1
Menjak, I.B.2
Brandao, L.R.3
-
6
-
-
78449282703
-
Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass
-
C. Gruenwald, C. Manlhiot, A.K. Chan Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass J Am Coll Cardiol 56 2010 1794 1802
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1794-1802
-
-
Gruenwald, C.1
Manlhiot, C.2
Chan, A.K.3
-
7
-
-
0033014430
-
Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery
-
G.D. Williams, S.L. Bratton, C. Ramamoorthy Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery Anesth Analg 89 1999 57 64
-
(1999)
Anesth Analg
, vol.89
, pp. 57-64
-
-
Williams, G.D.1
Bratton, S.L.2
Ramamoorthy, C.3
-
9
-
-
78649687391
-
Characterization of currently marketed heparin products: Reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests
-
A.M. Brustkern, L.F. Buhse, M. Nasr, A. Al-Hakim, D.A. Keire Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests Anal Chem 82 2010 9865 9870
-
(2010)
Anal Chem
, vol.82
, pp. 9865-9870
-
-
Brustkern, A.M.1
Buhse, L.F.2
Nasr, M.3
Al-Hakim, A.4
Keire, D.A.5
-
10
-
-
79251584385
-
A new approach for heparin standardization: Combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis
-
M.A. Lima, T.R. Rudd, E.H. de Farias A new approach for heparin standardization: combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis PLoS One 6 2011 e15970
-
(2011)
PLoS One
, vol.6
, pp. 15970
-
-
Lima, M.A.1
Rudd, T.R.2
De Farias, E.H.3
-
11
-
-
70449569318
-
Heparins: Process-related physico-chemical and compositional characteristics, fingerprints and impurities
-
L. Liverani, G. Mascellani, F. Spelta Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities Thromb Haemost 102 2009 846 853
-
(2009)
Thromb Haemost
, vol.102
, pp. 846-853
-
-
Liverani, L.1
Mascellani, G.2
Spelta, F.3
-
12
-
-
2442628599
-
The Aristotle score: A complexity-adjusted method to evaluate surgical results
-
F. Lacour-Gayet, D. Clarke, J. Jacobs The Aristotle score: a complexity-adjusted method to evaluate surgical results Eur J Cardiothorac Surg 25 2004 911 924
-
(2004)
Eur J Cardiothorac Surg
, vol.25
, pp. 911-924
-
-
Lacour-Gayet, F.1
Clarke, D.2
Jacobs, J.3
-
13
-
-
0034255628
-
Presentation of the International Nomenclature for Congenital Heart Surgery the long way from nomenclature to collection of validated data at the EACTS
-
F. Lacour-Gayet, B. Maruszewski, C. Mavroudis, J.P. Jacobs, M.J. Elliott Presentation of the International Nomenclature for Congenital Heart Surgery The long way from nomenclature to collection of validated data at the EACTS Eur J Cardiothorac Surg 18 2000 128 135
-
(2000)
Eur J Cardiothorac Surg
, vol.18
, pp. 128-135
-
-
Lacour-Gayet, F.1
Maruszewski, B.2
Mavroudis, C.3
Jacobs, J.P.4
Elliott, M.J.5
-
14
-
-
0024456056
-
Anti-thrombin activities of heparin Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin
-
B. Bray, D.A. Lane, J.M. Freyssinet, G. Pejler, U. Lindahl Anti-thrombin activities of heparin Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin Biochem J 262 1989 225 232
-
(1989)
Biochem J
, vol.262
, pp. 225-232
-
-
Bray, B.1
Lane, D.A.2
Freyssinet, J.M.3
Pejler, G.4
Lindahl, U.5
-
15
-
-
0021061174
-
Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
-
J. Choay, M. Petitou, J.C. Lormeau, P. Sinay, B. Casu, G. Gatti Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity Biochem Biophys Res Commun 116 1983 492 499
-
(1983)
Biochem Biophys Res Commun
, vol.116
, pp. 492-499
-
-
Choay, J.1
Petitou, M.2
Lormeau, J.C.3
Sinay, P.4
Casu, B.5
Gatti, G.6
-
16
-
-
0025962740
-
Antithrombin: Structure and function
-
C.W. Pratt, F.C. Church Antithrombin: structure and function Semin Hematol 28 1991 3 9
-
(1991)
Semin Hematol
, vol.28
, pp. 3-9
-
-
Pratt, C.W.1
Church, F.C.2
-
17
-
-
0027189646
-
A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection
-
R.J. Olds, D.A. Lane, C.H. Beresford, U. Abildgaard, P.M. Hughes, S.L. Thein A recurrent deletion in the antithrombin gene, AT106-108(-6 bp), identified by DNA heteroduplex detection Genomics 16 1993 298 299
-
(1993)
Genomics
, vol.16
, pp. 298-299
-
-
Olds, R.J.1
Lane, D.A.2
Beresford, C.H.3
Abildgaard, U.4
Hughes, P.M.5
Thein, S.L.6
-
19
-
-
0018758120
-
Anticoagulant activity of beef and hog mucosal heparins
-
M. Aiach, A. Kher, A. Michaud, J. Mardiguian, M. Trillou, M. Leclerc Anticoagulant activity of beef and hog mucosal heparins Thromb Res 14 1979 167 177
-
(1979)
Thromb Res
, vol.14
, pp. 167-177
-
-
Aiach, M.1
Kher, A.2
Michaud, A.3
Mardiguian, J.4
Trillou, M.5
Leclerc, M.6
-
21
-
-
0014721845
-
A collaborative study of heparins from different sources
-
D.R. Bangham, P.M. Woodward A collaborative study of heparins from different sources Bull World Health Organ 42 1970 129 149
-
(1970)
Bull World Health Organ
, vol.42
, pp. 129-149
-
-
Bangham, D.R.1
Woodward, P.M.2
-
22
-
-
0031870111
-
Do different heparin brands influence activated clotting times?
-
L. Dyck, R.M. Friesen Do different heparin brands influence activated clotting times? J Extra Corpor Technol 30 1998 73 76
-
(1998)
J Extra Corpor Technol
, vol.30
, pp. 73-76
-
-
Dyck, L.1
Friesen, R.M.2
-
23
-
-
0034533546
-
Characterization of unfractionated heparin: Comparison of materials from the last 50 years
-
B. Mulloy, E. Gray, T.W. Barrowcliffe Characterization of unfractionated heparin: comparison of materials from the last 50 years Thromb Haemost 84 2000 1052 1056
-
(2000)
Thromb Haemost
, vol.84
, pp. 1052-1056
-
-
Mulloy, B.1
Gray, E.2
Barrowcliffe, T.W.3
-
24
-
-
46749120559
-
Heparin is procoagulant in the absence of antithrombin
-
S.A. Smith, J.H. Morrissey Heparin is procoagulant in the absence of antithrombin Thrombos Haemostas 100 2008 160 162
-
(2008)
Thrombos Haemostas
, vol.100
, pp. 160-162
-
-
Smith, S.A.1
Morrissey, J.H.2
-
25
-
-
0028785452
-
Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
-
J. Hirsh, R. Raschke, T.E. Warkentin, J.E. Dalen, D. Deykin, L. Poller Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety Chest 108 Suppl 1995 258 275
-
(1995)
Chest
, vol.108
, Issue.SUPPL.
, pp. 258-275
-
-
Hirsh, J.1
Raschke, R.2
Warkentin, T.E.3
Dalen, J.E.4
Deykin, D.5
Poller, L.6
-
26
-
-
0025254425
-
Heparin dosing and monitoring for cardiopulmonary bypass A comparison of techniques with measurement of subclinical plasma coagulation
-
G.P. Gravlee, W.S. Haddon, H.K. Rothberger Heparin dosing and monitoring for cardiopulmonary bypass A comparison of techniques with measurement of subclinical plasma coagulation J Thorac Cardiovasc Surg 99 1990 518 527
-
(1990)
J Thorac Cardiovasc Surg
, vol.99
, pp. 518-527
-
-
Gravlee, G.P.1
Haddon, W.S.2
Rothberger, H.K.3
-
27
-
-
79956088575
-
A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery
-
Y. Fromes, K. Daghildjian, L. Caumartin A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery Anaesthesia 66 2011 488 492
-
(2011)
Anaesthesia
, vol.66
, pp. 488-492
-
-
Fromes, Y.1
Daghildjian, K.2
Caumartin, L.3
|